Skip to the content
Nice and Green - Leading Swiss Funding Firm
Contact
  • EN
  • DE
  • FR
  • Contact
  • About
  • Why us
  • Funding
  • Divestment
  • Code of Ethics
  • Careers
  • News
  • EN
  • DE
  • FR
– Latest news – Latest news
– Latest news – Latest news
  • All
  • Capital increase
  • Funding
  • Insight
Funding

26.01.2023

Nice & Green starts the execution of the EUR 90 million Convertible Notes Funding Program with Tessellis

Read more
Funding

22.07.2022

Nice & Green secures a financing of up to €1.7 million to Lucibel allowing it to accelerate its lead in the LED-based cosmetic solutions

Read more
Funding

05.07.2022

Nice & Green provides funding of €20 million to Oryzon for executing clinical trials in oncology and CNS

Read more
Funding

06.04.2022

Nice & Green renews its support to the Milan-listed telecom firm Tiscali with funding of EUR 21M and commits to participate into the financing of Tiscali’s business plan after its official merge with Linkem SpA

Read more
Funding

22.02.2022

Nice & Green supports LIDDS Pharma with up to 40.8 million SEK in funding to secure new partnerships based on the NanoZolid® technology

Read more
Next Page »

Stay connected.

Join us to stay up to date with the latest news.

Newsletter - EN
I accept the privacy policy *

Im Kontakt bleiben.

Bleiben Sie auf dem Laufenden.

Newsletter - DE
Ich akzeptiere die Datenschutzerklärung *

Être informé.

Recevoir notre actualité.

Newsletter - FR
J'accepte la politique de confidentialité *

Avenue Reverdil 12
1260 Nyon
Suisse

info@nicengreen.ch
LinkedIn

About
Why Us
Funding
Divestment

Geschäftsmodell
Wir über uns
Finanzierung
Beteiligungsverauserung

Activités
A propos
Financement
Cession de participations

Code of ethics
Careers
News
Legal

Ethik-Kodex
Karriere
News
Legal

Charte éthique
Carrières
News
Légal

© 2025 Nice and Green - Leading Swiss Funding Firm
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkNoPrivacy policy